Key result
Anticoagulation for isolated subsegmental PE lacks randomized trials despite low ~0.9% observational recurrent VTE rates.
Why the study?
Increased detection of subsegmental pulmonary embolism has raised critical questions regarding overdiagnosis, diagnostic variability, and optimal anticoagulation strategies in low-risk patients.
Does anticoagulation improve outcomes compared to observation in patients with isolated subsegmental pulmonary embolism?
Does anticoagulation improve outcomes compared to observation in patients with isolated subsegmental pulmonary embolism?
This review highlights clinical equipoise regarding the net benefit of anticoagulation for low-risk isolated SSPE due to low recurrence rates and non-trivial bleeding risks, emphasizing the need for randomized trials.
Answers are grounded in this paper and cite their sources.
Supports observation without anticoagulation in selected low-risk patients; leaves open optimal management pending randomized trials.
The widespread adoption of multidetector computed tomography pulmonary angiography has dramatically increased detection of subsegmental pulmonary embolism (SSPE), raising critical questions about overdiagnosis, optimal anticoagulation strategies, and appropriate follow-up.Despite increased detection, observational data demonstrate remarkably low short-term recurrence rates that do not differ significantly from more proximal pulmonary embolism.However, anticoagulation carries major bleeding risks, creating clinical equipoise about net benefit in low-risk isolated SSPE.Radiologist interpretation challenges compound the problem, with a substantial proportion of segmental and subsegmental emboli missed on initial reads in some series.This review presents current evidence on the epidemiology, diagnostic challenges, treatment controversies, and outcome data for SSPE, providing internists with actionable insights for clinical decision-making.Key findings include the lack of randomized controlled trial data to guide anticoagulation decisions, substantial inter-observer variability in SSPE diagnosis, and emerging evidence that selected low-risk patients may be safely observed without anticoagulation.
No takes yet. Share an insight, caveat, or question.
V. et al. (2026) conducted a review in Subsegmental pulmonary embolism. Anticoagulation vs. Observation was evaluated. Anticoagulation for isolated subsegmental pulmonary embolism lacks randomized trial evidence, while observational data show low 90-day recurrent venous thromboembolism rates of approximately 0.9%.
Synapse has enriched 10 related papers. Consider them for comparative context: